Allogene Therapeutics (ALLO)
(Real Time Quote from BATS)
$2.89 USD
-0.01 (-0.35%)
Updated May 14, 2024 11:48 AM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/7/24 |
---|---|
Current Quarter | -0.38 |
EPS Last Quarter | -0.38 |
Last EPS Surprise | 0.00% |
ABR | 1.61 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.65 |
Next Year | -1.69 |
EPS (TTM) | -1.71 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.04M | 0.04M | 0.15M | 0.15M |
# of Estimates | 4 | 4 | 5 | 3 |
High Estimate | 0.05M | 0.05M | 0.20M | 0.20M |
Low Estimate | 0.03M | 0.03M | 0.10M | 0.10M |
Year ago Sales | 0.04M | 0.04M | 0.16M | 0.15M |
Year over Year Growth Est. | 5.00% | 5.00% | -4.99% | 0.66% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.38 | -0.38 | -1.65 | -1.69 |
# of Estimates | 8 | 8 | 11 | 8 |
Most Recent Consensus | -0.41 | -0.41 | -1.67 | -1.79 |
High Estimate | -0.23 | -0.23 | -0.91 | -1.30 |
Low Estimate | -0.42 | -0.42 | -2.10 | -2.20 |
Year ago EPS | -0.53 | -0.37 | -2.01 | -1.65 |
Year over Year Growth Est. | 28.30% | -2.70% | 17.91% | -2.22% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 4 | 4 | 6 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.38 | -0.38 | -1.65 | -1.69 |
7 Days Ago | -0.38 | -0.38 | -1.65 | -1.69 |
30 Days Ago | -0.38 | -0.38 | -1.65 | -1.69 |
60 Days Ago | -0.42 | -0.42 | -1.83 | -1.85 |
90 Days Ago | -0.44 | -0.45 | -1.88 | -1.84 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.38 | -0.38 | -1.65 | -1.69 |
Zacks Consensus Estimate | -0.38 | -0.38 | -1.65 | -1.69 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.38 | -0.43 | -0.37 | -0.53 | NA |
Estimate | -0.38 | -0.47 | -0.53 | -0.59 | NA |
Difference | 0.00 | 0.04 | 0.16 | 0.06 | 0.07 |
Surprise | 0.00% | 8.51% | 30.19% | 10.17% | 12.22% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more